We are live on ! Find out more
Ruffer

Ruffer Portfolio holdings

AUM $1.98B Turnover 35.71%
1-Year Est. Return 11.67%
 

Ruffer is an independent investment manager owned and run by its partners, with a single global strategy aimed at not losing money over any rolling 12-month period. Jonathan Ruffer, who began as a stockbroker and then became a barrister, started it in 1994 with Robert Shirley, 14th Earl Ferrers, and Jane Tufnell, and it became Ruffer LLP in 2004. The firm starts by weighing the risks it sees in markets and picking assets that should protect the portfolio if they come true, then takes on growth mainly through global stocks. It runs a stock-market-listed investment company, and its clients include pension plans, charities and family offices.

This Fund
S&P 500
This Quarter Est. Return
+18.22%
1 Year Est. Return
+11.67%
3 Year Est. Return
+123.28%
5 Year Est. Return
+179.62%
10 Year Est. Return
+587.82%
AUM
$3.43B
AUM Growth
-$91.6M
Cap. Flow
-$572M
Cap. Flow %
-16.67%
Top 10 Hldgs %
62.86%
Holding
98
New
5
Increased
18
Reduced
40
Closed
17
Avg Time Held
2.4 years
Top 10 Avg Time Held
1.1 years
Top 20 Avg Time Held
1.6 years

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$294M
2
FCX icon
Freeport-McMoran
FCX
+$172M
3
EHTH icon
eHealth
EHTH
+$76.5M
4
DOW icon
Dow Inc
DOW
+$55.4M
5
GM icon
General Motors
GM
+$38.8M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$318M
2
AMGN icon
Amgen
AMGN
+$218M
3
DIS icon
Walt Disney
DIS
+$133M
4
ATVI
Activision Blizzard
ATVI
+$111M
5
CI icon
Cigna
CI
+$108M

Sector Composition

Rank Sector Weight
1 Materials 32.47%
2 Healthcare 23.38%
3 Communication Services 13.54%
4 Energy 13.02%
5 Consumer Discretionary 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DIS icon
1
Walt Disney
DIS
$205B
$462M 13.48%
3,195,119
-953,270
-23% -$133M
2016 Q4
12 quarters
BMY icon
2
Bristol-Myers Squibb
BMY
$130B
$337M 9.83%
5,253,374
+5,135,274
+4,348% +$294M
2019 Q2
2 quarters
FCX icon
3
Freeport-McMoran
FCX
$85B
$220M 6.41%
16,724,976
+15,628,927
+1,426% +$172M
2018 Q3
5 quarters
XOM icon
4
ExxonMobil
XOM
$696B
$199M 5.81%
2,851,928
-599,351
-17% -$41.4M
2013 Q2
26 quarters
KGC icon
5
Kinross Gold
KGC
$24.5B
$199M 5.8%
41,893,161
+1,557,682
+4% +$7.03M
2013 Q2
26 quarters
NOV icon
6
NOV
NOV
$6.45B
$178M 5.18%
7,089,186
-104,331
-1% -$2.35M
2018 Q2
6 quarters
CI icon
7
Cigna
CI
$78.3B
$164M 4.77%
799,501
-587,272
-42% -$108M
2018 Q3
5 quarters
CNC icon
8
Centene
CNC
$35.3B
$160M 4.66%
2,540,551
-288,403
-10% -$15.6M
2019 Q3
1 quarter
WPM icon
9
Wheaton Precious Metals
WPM
$59.7B
$126M 3.67%
4,225,971
-30,688
-0.7% -$839K
2015 Q3
17 quarters
GM icon
10
General Motors
GM
$72.5B
$111M 3.24%
3,036,570
+1,067,771
+54% +$38.8M
2018 Q2
6 quarters
FL icon
11
DELISTED
Foot Locker
FL
$108M 3.15%
2,770,975
-1,005,705
-27% -$42.4M
2017 Q4
8 quarters
HUM icon
12
Humana
HUM
$54B
$102M 2.97%
277,936
-108,612
-28% -$34.4M
2019 Q2
2 quarters
EHTH icon
13
eHealth
EHTH
$13.4M
$94.7M 2.76%
+985,957
New +$76.5M
2019 Q4
0 quarters
NEM icon
14
Newmont
NEM
$118B
$91.1M 2.66%
2,096,743
+59,761
+3% +$2.34M
2015 Q4
16 quarters
ATVI
15
DELISTED
Activision Blizzard
ATVI
$90.6M 2.64%
1,523,788
-2,001,932
-57% -$111M
2019 Q2
2 quarters
IAG icon
16
IAMGOLD
IAG
$9.8B
$81.3M 2.37%
21,698,088
+645,028
+3% +$2.28M
2018 Q4
4 quarters
DOW icon
17
Dow Inc
DOW
$23.9B
$72.1M 2.1%
1,317,649
+1,072,714
+438% +$55.4M
2019 Q2
2 quarters
AU icon
18
AngloGold Ashanti
AU
$43.7B
$70.8M 2.06%
3,166,016
-85,539
-3% -$1.72M
2015 Q2
18 quarters
VAL icon
19
DELISTED
Valaris plc Class A Ordinary Share
VAL
$64.3M 1.88%
9,812,973
+2,016,343
+26% +$9.8M
2019 Q3
1 quarter
GFI icon
20
Gold Fields
GFI
$31.6B
$51.3M 1.5%
7,767,105
-794,010
-9% -$4.5M
2013 Q2
26 quarters
SYF icon
21
Synchrony
SYF
$22.5B
$48.9M 1.43%
1,358,735
-153,161
-10% -$5.48M
2019 Q1
3 quarters
B icon
22
Barrick Mining
B
$61.2B
$47.6M 1.39%
2,563,928
+479,741
+23% +$8.23M
2013 Q4
24 quarters
CHKP icon
23
Check Point Software Technologies
CHKP
$15B
$34.4M 1%
309,526
-9,281
-3% -$1.04M
2018 Q4
4 quarters
LTHM
24
DELISTED
Livent Corporation
LTHM
$32.6M 0.95%
3,814,666
-17,441
-0.5% -$133K
2019 Q2
2 quarters
DD icon
25
DuPont de Nemours
DD
$20.4B
$26.6M 0.77%
329,441
+66,326
+25% +$5.51M
2017 Q3
9 quarters

Similar funds

Ruffer's Q4 2019 Portfolio in Review

As of Q4 2019, Ruffer held 98 positions worth $3.43B, down 2.6% from $3.52B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Ruffer withdrew a net $572M in Q4 2019, closing 17 positions and reducing 40 holdings. Its most notable exit was Celgene Corp, an estimated $318M position sold in full.

By sector, the portfolio is most concentrated in Materials at 32% of assets, up from 24% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Ruffer opened a new position in eHealth worth $94.7M.

  • Ruffer's largest Q4 2019 buy was eHealth: 985,957 shares worth $94.7M.
  • Ruffer added most to Bristol-Myers Squibb in Q4 2019, an estimated $294M increase.
  • Ruffer's biggest Q4 2019 reduction was Amgen, cutting an estimated $218M.
  • Ruffer fully exited Celgene Corp in Q4 2019, selling an estimated $318M.
  • Ruffer's ten largest holdings make up 63% of its $3.43B portfolio in Q4 2019.
  • Ruffer opened 5 new positions and closed 17 in Q4 2019.
  • Ruffer's portfolio value fell 2.6% quarter-over-quarter to $3.43B.

Based on Ruffer's 13F filing for Q4 2019, filed 6 Feb 2020.